<code id='D1A4246970'></code><style id='D1A4246970'></style>
    • <acronym id='D1A4246970'></acronym>
      <center id='D1A4246970'><center id='D1A4246970'><tfoot id='D1A4246970'></tfoot></center><abbr id='D1A4246970'><dir id='D1A4246970'><tfoot id='D1A4246970'></tfoot><noframes id='D1A4246970'>

    • <optgroup id='D1A4246970'><strike id='D1A4246970'><sup id='D1A4246970'></sup></strike><code id='D1A4246970'></code></optgroup>
        1. <b id='D1A4246970'><label id='D1A4246970'><select id='D1A4246970'><dt id='D1A4246970'><span id='D1A4246970'></span></dt></select></label></b><u id='D1A4246970'></u>
          <i id='D1A4246970'><strike id='D1A4246970'><tt id='D1A4246970'><pre id='D1A4246970'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:1955
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Advocates call out 'SNL' over stereotypes, errors in sickle cell skit
          Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

          CraigF.Walker/TheBostonGlobeMaryBrownwassippingcoffeeathomeinOntario,Calif.,Sundaymorningwhenafriend

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Carvykti CAR

          Acutemyeloidleukemiacellsamidbloodflow.AdobeTheFoodandDrugAdministrationissuedachangetothewarninglab